21 – 30 of 40
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2012
-
Mark
Global microRNA expression profiling of high-risk ER+ breast cancers from patients receiving adjuvant tamoxifen mono-therapy : a DBCG study
(
- Contribution to journal › Article
- 2011
-
Mark
Time dependent effects of adjuvant tamoxifen therapy on cerebrovascular disease: results from a randomised trial
(
- Contribution to journal › Article
- 2010
-
Mark
Genetic variants on chromosome 5p12 are associated with risk of breast cancer in African American women: the Black Women's Health Study
(
- Contribution to journal › Article
-
Mark
Radiotherapy in Early Breast Cancer
(
- Thesis › Doctoral thesis (compilation)
-
Mark
Prognostic and Treatment Predictive Markers Associated with Cyclin D1 Gene Amplification and Epithelial-Mesenchymal Transition in Breast Cancer
(
- Thesis › Doctoral thesis (compilation)
-
Mark
17 beta-Hydroxysteroid dehydrogenase type 1 as predictor of tamoxifen response in premenopausal breast cancer
(
- Contribution to journal › Article
- 2008
-
Mark
Epidermal growth factor receptor (EGFR) and the estrogen receptor modulator amplified in breast cancer (AIB1) for predicting clinical outcome after adjuvant tamoxifen in breast cancer.
(
- Contribution to journal › Article
- 2007
-
Mark
Estrogen receptor beta expression is associated with tamoxifen response in ER alpha-negative breast carcinoma
(
- Contribution to journal › Article
-
Mark
Radiotherapy and tamoxifen after mastectomy in postmenopausal women - 20 year follow-up of the South Sweden Breast Cancer group randomised trial SSBCG II : I
(
- Contribution to journal › Article
-
Mark
Differential effects of selective oestrogen receptor modulators (SERMs) tamoxifen, ospemifene and raloxifene on human osteoclasts in vitro
(
- Contribution to journal › Article